Bristol-Myers Squibb Co to Discuss ESMO Highlights Call Transcript

Sep 28, 2019 / 05:30PM GMT
John E. Elicker - Bristol-Myers Squibb Company - SVP of Corporate Affairs & IR

Is the microphone on? Okay. Thank you, gentlemen. Just for those folks in the room and -- for those folks in the room -- the mic is definitely now on. And for folks on the phone: We're not (inaudible) because, for everybody who isn't here live, that's when we told them the webcast would start. So if you want to bear with us for another 10 or 15 minutes. Do whatever you're going to do...

Unidentified Participant -

It's 7:30...

John E. Elicker - Bristol-Myers Squibb Company - SVP of Corporate Affairs & IR

My clock says 7:15.

Unidentified Participant -

7:30.

John E. Elicker - Bristol-Myers Squibb Company - SVP of Corporate Affairs & IR

Oh, all right then. Then we'll get started. Like I said -- thank you. So thanks, everybody, for being here.

My name is John Elicker. We're here to discuss ESMO 2019; really fortunate to have Dr. Samit Hirawat here

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot